Marcel Meury
Overview
Explore the profile of Marcel Meury including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
1456
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Momont C, Dang H, Zatta F, Hauser K, Wang C, di Iulio J, et al.
Nature
. 2023 Jul;
619(7970):E50.
PMID: 37407829
No abstract available.
2.
Momont C, Dang H, Zatta F, Hauser K, Wang C, di Iulio J, et al.
Nature
. 2023 May;
618(7965):590-597.
PMID: 37258672
Rapidly evolving influenza A viruses (IAVs) and influenza B viruses (IBVs) are major causes of recurrent lower respiratory tract infections. Current influenza vaccines elicit antibodies predominantly to the highly variable...
3.
Bassi J, Giannini O, Silacci-Fregni C, Pertusini L, Hitz P, Terrot T, et al.
PLoS One
. 2022 Feb;
17(2):e0263328.
PMID: 35143540
Patients on dialysis are at risk of severe course of SARS-CoV-2 infection. Understanding the neutralizing activity and coverage of SARS-CoV-2 variants of vaccine-elicited antibodies is required to guide prophylactic and...
4.
Lempp F, Soriaga L, Montiel-Ruiz M, Benigni F, Noack J, Park Y, et al.
Nature
. 2021 Aug;
598(7880):342-347.
PMID: 34464958
SARS-CoV-2 infection-which involves both cell attachment and membrane fusion-relies on the angiotensin-converting enzyme 2 (ACE2) receptor, which is paradoxically found at low levels in the respiratory tract, suggesting that there...
5.
Starr T, Czudnochowski N, Liu Z, Zatta F, Park Y, Addetia A, et al.
Nature
. 2021 Jul;
597(7874):97-102.
PMID: 34261126
An ideal therapeutic anti-SARS-CoV-2 antibody would resist viral escape, have activity against diverse sarbecoviruses, and be highly protective through viral neutralization and effector functions. Understanding how these properties relate to...
6.
Starr T, Czudnochowski N, Zatta F, Park Y, Liu Z, Addetia A, et al.
bioRxiv
. 2021 Apr;
PMID: 33851154
An ideal anti-SARS-CoV-2 antibody would resist viral escape , have activity against diverse SARS-related coronaviruses , and be highly protective through viral neutralization and effector functions . Understanding how these...
7.
Thomson E, Rosen L, Shepherd J, Spreafico R, da Silva Filipe A, Wojcechowskyj J, et al.
Cell
. 2021 Feb;
184(5):1171-1187.e20.
PMID: 33621484
SARS-CoV-2 can mutate and evade immunity, with consequences for efficacy of emerging vaccines and antibody therapeutics. Here, we demonstrate that the immunodominant SARS-CoV-2 spike (S) receptor binding motif (RBM) is...
8.
Tortorici M, Beltramello M, Lempp F, Pinto D, Dang H, Rosen L, et al.
Science
. 2020 Sep;
370(6519):950-957.
PMID: 32972994
Efficient therapeutic options are needed to control the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that has caused more than 922,000 fatalities as of 13 September 2020. We...
9.
Leisinger F, Burn R, Meury M, Lukat P, Seebeck F
J Am Chem Soc
. 2019 Apr;
141(17):6906-6914.
PMID: 30943021
Ergothioneine is an emergent factor in cellular redox biochemistry in humans and pathogenic bacteria. Broad consensus has formed around the idea that ergothioneine protects cells against reactive oxygen species. The...
10.
Stampfli A, Goncharenko K, Meury M, Dubey B, Schirmer T, Seebeck F
J Am Chem Soc
. 2019 Mar;
141(13):5275-5285.
PMID: 30883103
Sulfoxide synthases are nonheme iron enzymes that catalyze oxidative carbon-sulfur bond formation between cysteine derivatives and N-α-trimethylhistidine as a key step in the biosynthesis of thiohistidines. The complex catalytic mechanism...